Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer |
Advanced HR+/HER2- Breast Cancer | Phase1 | Canada France Italy Japan Netherlands Singapore South Korea United States View all |
NCT07604571 |
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy |
Extensive-stage Small Cell Lung Cancer (ES-SCLC) | Phase1, Phase2 | Australia Singapore South Korea United States View all |
NCT07564401 |
A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients |
Familial Mediterranean Fever, Still Disease, Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still Disease | Switzerland | NCT07517250 | |
A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany |
Leukemia, Chronic Myeloid | Germany | NCT07549516 | |
Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment |
Advanced Malignancies and Hepatic Impairment | Phase1 | France Italy Spain United Kingdom View all |
NCT07422610 |
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer |
Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase1 | Australia Canada Germany Italy Japan South Korea Spain United States View all |
NCT07570979 |
Remibrutinib Open Label Roll-over Post-trial Access Protocol |
Indication of the Parent Protocol | Phase3 | Bulgaria Canada Colombia Czechia France Poland South Korea Spain Vietnam View all |
NCT07456891 |
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy |
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) | Phase3 | Australia Belgium China France Germany Italy Japan Netherlands South Korea Spain United Kingdom United States View all |
NCT07498426 |
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP), Primary Evans Syndrome (ES) | Phase2 | United States | NCT07421167 |
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies |
Heterozygous or Homozygous Familial Hypercholesterolemia | Phase3 | Taiwan United States |
NCT05682378 |